Jysk Fliserens & Algebehandling ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 19.8% 10.9% 10.9%  
Credit score (0-100)  0 0 5 22 17  
Credit rating  N/A N/A C B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 283 550  
EBITDA  0.0 0.0 0.0 154 -143  
EBIT  0.0 0.0 0.0 105 -143  
Pre-tax profit (PTP)  0.0 0.0 0.0 104.6 -143.4  
Net earnings  0.0 0.0 0.0 78.3 -126.1  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 105 -143  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 40.0 147 255  
Shareholders equity total  0.0 0.0 40.0 118 -7.8  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 236  
Balance sheet total (assets)  0.0 0.0 40.0 197 300  

Net Debt  0.0 0.0 0.0 -47.3 236  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 283 550  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 94.4%  
Employees  0 0 0 1 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 40 197 300  
Balance sheet change%  0.0% 0.0% 0.0% 393.3% 52.3%  
Added value  0.0 0.0 0.0 104.6 -143.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 40 58 108  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 -1.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 37.0% -26.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 88.2% -56.7%  
ROI %  0.0% 0.0% 0.0% 132.1% -81.0%  
ROE %  0.0% 0.0% 0.0% 98.9% -60.2%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 100.0% 60.0% -2.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -30.8% -164.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% -3,032.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.6 0.1  
Current Ratio  0.0 0.0 0.0 0.6 0.1  
Cash and cash equivalent  0.0 0.0 0.0 47.3 0.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -28.7 -262.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 105 -72  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 154 -72  
EBIT / employee  0 0 0 105 -72  
Net earnings / employee  0 0 0 78 -63